Serologic Follow-Up and Treatment Response in Syphilis

Follow-Up Testing Schedule

• The Centers for Disease Control and Prevention recommends clinical and serologic evaluation at 6 months and 12 months after treatment for primary and secondary syphilis 1, 2
• More frequent evaluation (at 3-month intervals) is recommended if follow-up is uncertain 1
• HIV-infected patients require more frequent monitoring at 3-month intervals instead of 6-month intervals 2, 3

Indicators of Treatment Failure

• Treatment failure should be suspected when clinical signs or symptoms persist or recur 1, 2
• A sustained fourfold increase in nontreponemal test titer compared with baseline indicates treatment failure 1, 2
• Failure of nontreponemal test titers to decline fourfold within 6 months after therapy for primary or secondary syphilis indicates treatment failure 1, 2, 5

Management of Treatment Failure

• When treatment failure is suspected, re-evaluate for HIV infection 1, 2, 5
• Perform CSF examination unless reinfection is certain, as treatment failure may result from unrecognized CNS infection 1, 2, 5
• Re-treat with three weekly injections of benzathine penicillin G 2.4 million units IM, unless CSF examination indicates neurosyphilis 1, 2, 5

Critical Testing Principles

• Use the same testing method (VDRL or RPR) by the same laboratory for sequential tests, as results are not directly comparable between methods 4, 6, 3
• Treponemal tests (FTA-ABS, TPHA) remain positive for life and should not be used to assess treatment response 4, 3
• A fourfold change in titer is considered clinically significant (e.g., from 1:32 to 1:8) 3, 5

Special Populations

• HIV-infected patients may have atypical serologic responses and require more frequent monitoring every 3 months 2, 3, 5, 6
• HIV-infected patients should undergo CSF examination for late-latent syphilis or syphilis of unknown duration 3